ArticlePloS one2026
White Feces Syndrome is closely linked to impaired antioxidant capacity, the aquaculture environment, and microbial dysbiosis in Litopenaeus vannamei reared in small-pond culture system.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhite feces syndrome (WFS) is a major health problem affecting intensive shrimp aquaculture, but its underlying mechanisms remain unclear. Increasing evidence suggests that WFS may involve complex interactions among host physiological status, intestinal microbial dysbiosis, and environmental microbial communities. However, the relationships among these factors within commercial shrimp culture systems remain poorly understood.
objectivesThis study aimed to investigate the associations among intestinal antioxidant capacity, intestinal microbiota, sediment microbial communities, and water quality parameters in Litopenaeus vannamei affected by WFS under small-pond culture conditions.
methodsHealthy and WFS-affected shrimp were collected from a commercial shrimp farm in Zhanjiang, Guangdong Province, China. Intestinal antioxidant parameters, including total antioxidant capacity (T-AOC), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA), were determined. Intestinal and sediment microbial communities were analyzed using 16S rRNA gene sequencing. Water quality parameters and microbial community composition were compared between healthy and WFS groups.
resultsCompared with healthy shrimp, WFS-affected shrimp exhibited significantly increased intestinal MDA levels and decreased activities of T-AOC, SOD, and GSH-Px, indicating an imbalance in antioxidant status. Significant differences in intestinal microbial community composition were observed between groups, as confirmed by beta-diversity analysis (PERMANOVA, R2 = 0.407, P = 0.022). WFS-associated microbial alterations included changes in dominant bacterial taxa and predicted microbial functional potential related to metabolism. The dominant taxa, referring to the most abundant microbial groups based on relative abundance, differed between healthy and WFS-affected shrimp. Sediment microbial communities also showed substantial compositional shifts, suggesting alterations in the surrounding microbial environment. In addition, nitrate and total nitrogen concentrations were significantly reduced in the WFS group.
conclusionThese findings indicate that WFS occurrence is associated with coordinated alterations in shrimp antioxidant status, intestinal microbial structure, sediment microbial communities, and environmental conditions. This study provides new insights into WFS from a host-microbiota-environment interaction perspective and highlights potential indicators for monitoring shrimp health in aquaculture systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.